My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
May 1, 2008
IDSA Endorses Two Vaccine Financing Bills

IDSA recently endorsed two critical bills addressing vaccine financing sponsored by a leading legislator on health issues

The Vaccines for Children Access Act of 2008 (H.R. 4990) would expand the category of children and adolescents who are eligible for the Vaccines for Children (VFC) program to include the under-insured who are vaccinated at any public health clinic.  The VFC program is federally funded and provides vaccines to all eligible children, through the age of 18, who might not otherwise be able to afford them.

The Vaccines for the Uninsured Adult Act of 2008 (H.R. 4993) would establish a Vaccines for Uninsured Adults Program (VFUA), providing routinely recommended vaccines to eligible adults, and would be modeled on the successful VFC program. 

On a related front, at a recent meeting of the National Vaccine Advisory Committee (NVAC), IDSA urged the Committee to recommend expanding VFC eligibility and also to support adding an administration fee so that health care providers are adequately reimbursed for vaccinating children and adolescents. 
NVAC provides recommendations for vaccine policy to the Department of Health and Human Services.

Both pieces of legislation were sponsored by Rep. Henry Waxman (D-CA).   IDSA’s letter of support to Rep. Waxman is available online.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

FDA Lowers Vancomycin Breakpoints for Staph Infections
WHO Reports Progress on Dracunculiasis Eradication
IDSA Literature Review - April 2008
Brazil Has Large Dengue Fever Outbreak
Malaria Reported in Bahamas
Polio Eradication Update: Cases Down Overall, But Type 3 Cases Up
Rift Valley Fever Outbreak in Madagascar
Vietnam Reports Cholera Outbreak
Yellow Fever Reported in Liberia, Argentina
Cefixime Available Again in the United States
Drug Approvals, Recalls, Adverse Events Update
In the IDSA Journals
From the President
IDSA Endorses Two Vaccine Financing Bills
IDSA Urges FDA to Dedicate Resources to Antimicrobial Resistance
Members on the Move
Welcome, New IDSA Members!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.